Ionis Pharmaceuticals (IONS) Interest Coverage Ratio (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Interest Coverage Ratio of 6.16 for Q2 2026, down 137.9% year-over-year from 16.26 in Q2 2025, and up 7.64% quarter-over-quarter from 6.67 in Q1 2026.
Ionis Pharmaceuticals (IONS) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Interest Coverage Ratio history runs 18 years deep, the most recent figure standing at 6.16 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio fell 137.9% year-over-year to 6.16; the TTM figure through Jun 2026 stood at 35.8 (down 15.53% YoY), while the FY2025 annual figure was 0.31, up 26.62% from the prior year.
- Interest Coverage Ratio for Q2 2026 stood at 6.16, up from 6.67 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 16.26 in Q2 2025, with the low at 39.84 in Q4 2025.
- The 5-year median for Interest Coverage Ratio is 5.98 (2024), against an average of 9.16.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio sank 658.34% in 2024, then soared 380.43% in 2025.
- Ionis Pharmaceuticals' Interest Coverage Ratio stood at 35.15 in 2022, then surged by 110.95% to 3.85 in 2023, then plunged by 658.34% to 21.5 in 2024, then tumbled by 85.32% to 39.84 in 2025, then surged by 84.53% to 6.16 in 2026.
- Business Quant data shows IONS's Interest Coverage Ratio at 6.16 in Q2 2026, 6.67 in Q1 2026, and 39.84 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | -6.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.16 |
| Mar 31, 2026 | -6.67 |
| Dec 31, 2025 | -39.84 |
| Sep 30, 2025 | -0.70 |
| Jun 30, 2025 | 16.26 |
| Mar 31, 2025 | -15.79 |
| Dec 31, 2024 | -21.50 |
| Sep 30, 2024 | -13.89 |
| Jun 30, 2024 | -5.80 |
| Mar 31, 2024 | -12.46 |
| Dec 31, 2023 | 3.85 |
| Sep 30, 2023 | -8.80 |
| Jun 30, 2023 | -4.24 |
| Mar 31, 2023 | -5.62 |
| Dec 31, 2022 | -35.15 |
| Sep 30, 2022 | -1.81 |
| Jun 30, 2022 | -3.57 |
| Mar 31, 2022 | -3.02 |
| Dec 31, 2021 | 37.89 |
| Sep 30, 2021 | -6.05 |